Developer docs
API playgroundTry for free, no card

Search company profiles

OCV

Full company profile

uuid0002684

Namestring
OCV
Legal namestring
OCV Management LLC
Websiteurl
ocvpartners.com
Company typeenum
Private
Founded yearint
2016
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLos Angeles, United States
HQ citystring
Los Angeles
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture capital investing, growth stage funding, technology investments, healthcare investments, portfolio company support
Industry3 codes
PRIMARYFSANAAAC
Late-Stage Venture Capital (Series C+)
SECONDARYFSANACAA
Technology & Software Growth Equity
SECONDARYFSANACAB
Healthcare & Life Sciences Growth Equity
NAICS code2 codes
  • Portfolio Management and Investment Advice523940
  • Funds, Trusts, and Other Financial Vehicles525
SIC code1 code
  • Investment Advice6282
Product category
Venture Capital
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Fund Management
TypeLicensing Royalties
Description

OCV generates returns through management fees and carried interest from their venture funds. They invest in portfolio companies and realize returns through exits via IPOs and acquisitions.

ocvpartners.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

OCV Partners is a Los Angeles-based venture capital firm that provides equity capital and operational expertise to early and growth-stage technology and healthcare companies. The firm deploys flexible capital across all stages of a company's growth cycle and combines investment with hands-on company-building support from former founders. Its investment focus spans Technology (SaaS, FinTech, PropTech) and Healthcare (Healthcare SaaS, Digital Health, MedTech, BioTech) sectors.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 165+ software companies acquired through J2 Global experience
+1 more record
Product overview1 text field

OCV Partners operates as a single unified investment platform rather than a modular product suite. The firm provides venture capital investment services to portfolio companies, offering flexible capital deployment across all growth stages, from early-stage to IPO and beyond. Their core offering combines equity investment with operational expertise, leveraging the team's experience from building companies that have scaled across industries and countries. The firm focuses on two primary sectors: Technology (SaaS, FinTech, and PropTech) and Healthcare (Healthcare SaaS, Digital Health, MedTech, and BioTech).

Product and service1 record
1OCV Partners Investment Services
CategoryVenture Capital / Private Equity
Description

Venture capital investment services providing flexible equity capital and operational expertise to early and growth-stage technology and healthcare companies. OCV invests across all stages of a company's growth cycle and supports portfolio companies in SaaS, FinTech, PropTech, Healthcare SaaS, Digital Health, MedTech, and BioTech sectors with board representation, strategic guidance, and operational support.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Venture capital firm with a strong focus on technology and healthcare investments. Direct co-investor with OCV in Rad AI, where Khosla led the Series B. Highly comparable in stage focus (Series A-C) and sector overlap (SaaS, AI, biotech).

TypeDirect peer
Description

Healthcare and technology-focused venture capital firm. Co-led ByHeart's Series A alongside OCV. Directly comparable in healthcare/biotech investment thesis and stage focus.

TypeDirect peer
Description

Early-to-growth stage venture firm investing at the intersection of technology and health/life sciences. Led Rad AI Series A and participated in subsequent rounds alongside OCV — directly comparable in stage and sector thesis.

TypeDirect peer
Description

Israel-focused venture capital firm investing in deep tech and enterprise software. Co-invested with OCV in Orca AI across multiple rounds; directly comparable as an early-stage tech investor with strong Israeli sourcing.

5D1 Capital Partners
TypeDirect peer
Description

Technology-focused investment firm backing growth-stage companies. Co-led ByHeart's Series A with OCV. Comparable in stage focus (growth equity) and consumer/health tech overlap.

TypeDirect peer
Description

Investment manager focused on public and private growth companies. Led Precision BioSciences Series B with OCV participation. Comparable in growth-stage biotech and tech investing.

TypeBroad incumbent
Description

Major technology-focused venture capital firm with broad coverage across SaaS, fintech, healthcare, and bio. Operates at significantly larger fund sizes but with overlapping sector thesis (SaaS, healthcare, AI) and similar stage flexibility.

TypeBroad incumbent
Description

Multi-stage venture capital firm investing across technology and healthcare, including digital health and biotech. Larger and more diversified than OCV but with overlapping thesis and operating value-add orientation.

TypeBroad incumbent
Description

Long-established venture capital firm with deep SaaS and subscription software expertise — directly mirroring OCV's stated SaaS/subscription focus and operating playbook heritage from J2 Global.

TypeEmerging player
Description

Venture firm founded by Bill Maris investing at the intersection of technology and healthcare/life sciences. Comparable in mid-sized fund profile, tech-healthcare crossover thesis, and stage focus similar to OCV.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment22 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

OCV

Venture Capitalocvpartners.com

OCV firmographics

Firmographics
Name
OCV
Legal name
OCV Management LLC
Website
https://ocvpartners.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

OCV industry classification

Industry
Product category
Venture Capital
NAICS
Portfolio Management and Investment Advice (523940), Funds, Trusts, and Other Financial Vehicles (525)
SIC
Investment Advice (6282)
akta.pro industry
PRIMARYFSANAAAC
Late-Stage Venture Capital (Series C+)
SECONDARYFSANACAA
Technology & Software Growth Equity
SECONDARYFSANACAB
Healthcare & Life Sciences Growth Equity

Keywords

  • Venture capital investing
  • Growth stage funding
  • Technology investments
  • Healthcare investments
  • Portfolio company support

Where OCV is headquartered

Location

Headquarters

HQ city
Los Angeles
HQ country
United States
HQ region
North America

Offices1 record

Markets served

OCV business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Fund Management: OCV generates returns through management fees and carried interest from their venture funds. They invest in portfolio companies and realize returns through exits via IPOs and acquisitions.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

OCV product offering

Product offering

Core offering

OCV Partners is a Los Angeles-based venture capital firm that provides equity capital and operational expertise to early and growth-stage technology and healthcare companies. The firm deploys flexible capital across all stages of a company's growth cycle and combines investment with hands-on company-building support from former founders. Its investment focus spans Technology (SaaS, FinTech, PropTech) and Healthcare (Healthcare SaaS, Digital Health, MedTech, BioTech) sectors.

Product overview

OCV Partners operates as a single unified investment platform rather than a modular product suite. The firm provides venture capital investment services to portfolio companies, offering flexible capital deployment across all growth stages, from early-stage to IPO and beyond. Their core offering combines equity investment with operational expertise, leveraging the team's experience from building companies that have scaled across industries and countries. The firm focuses on two primary sectors: Technology (SaaS, FinTech, and PropTech) and Healthcare (Healthcare SaaS, Digital Health, MedTech, and BioTech).

Differentiator

Problem solved

Functional benefit

Products and services

  • OCV Partners Investment Services Venture capital investment services providing flexible equity capital and operational expertise to early and growth-stage technology and healthcare companies. OCV invests across all stages of a company's growth cycle and supports portfolio companies in SaaS, FinTech, PropTech, Healthcare SaaS, Digital Health, MedTech, and BioTech sectors with board representation, strategic guidance, and operational support.

Quantifiable outcome

  • 165+ software companies acquired through J2 Global experience
  • +1 more outcomes

Companies that use OCV

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles3 records

OCV technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

OCV partnerships and signals

Strategic signal

Scale indicators9 records

Recent moves9 records

Expansion highlights5 records

OCV competitors and assessment

Company assessment

Direct peers

  • Khosla Ventures: Venture capital firm with a strong focus on technology and healthcare investments. Direct co-investor with OCV in Rad AI, where Khosla led the Series B. Highly comparable in stage focus (Series A-C) and sector overlap (SaaS, AI, biotech).
  • Polaris Partners: Healthcare and technology-focused venture capital firm. Co-led ByHeart's Series A alongside OCV. Directly comparable in healthcare/biotech investment thesis and stage focus.
  • Artis Ventures: Early-to-growth stage venture firm investing at the intersection of technology and health/life sciences. Led Rad AI Series A and participated in subsequent rounds alongside OCV — directly comparable in stage and sector thesis.
  • MizMaa Ventures: Israel-focused venture capital firm investing in deep tech and enterprise software. Co-invested with OCV in Orca AI across multiple rounds; directly comparable as an early-stage tech investor with strong Israeli sourcing.
  • D1 Capital Partners: Technology-focused investment firm backing growth-stage companies. Co-led ByHeart's Series A with OCV. Comparable in stage focus (growth equity) and consumer/health tech overlap.
  • ArrowMark Partners: Investment manager focused on public and private growth companies. Led Precision BioSciences Series B with OCV participation. Comparable in growth-stage biotech and tech investing.

Broad incumbents

  • Andreessen Horowitz (a16z): Major technology-focused venture capital firm with broad coverage across SaaS, fintech, healthcare, and bio. Operates at significantly larger fund sizes but with overlapping sector thesis (SaaS, healthcare, AI) and similar stage flexibility.
  • General Catalyst: Multi-stage venture capital firm investing across technology and healthcare, including digital health and biotech. Larger and more diversified than OCV but with overlapping thesis and operating value-add orientation.
  • Bessemer Venture Partners: Long-established venture capital firm with deep SaaS and subscription software expertise — directly mirroring OCV's stated SaaS/subscription focus and operating playbook heritage from J2 Global.

Emerging players

  • Section 32: Venture firm founded by Bill Maris investing at the intersection of technology and healthcare/life sciences. Comparable in mid-sized fund profile, tech-healthcare crossover thesis, and stage focus similar to OCV.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

OCV social profiles

Digital presence

OCV financial estimates

Financial estimate

Revenue estimate

Valuation estimate

OCV leadership team

Management profile

Number of profiles

Profiles4 records

OCV funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

OCV M&A and investment

M&A and investment

M&A

Investments22 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about OCV

What does OCV do?

OCV Partners is a Los Angeles-based venture capital firm that provides equity capital and operational expertise to early and growth-stage technology and healthcare companies. The firm deploys flexible capital across all stages of a company's growth cycle and combines investment with hands-on company-building support from former founders. Its investment focus spans Technology (SaaS, FinTech, PropTech) and Healthcare (Healthcare SaaS, Digital Health, MedTech, BioTech) sectors.

Is OCV a public or private company?

OCV is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was OCV founded?

OCV was founded in 2016. It employs 11 to 50 people.

Where is OCV based?

OCV is headquartered in Los Angeles, United States, in the North America region.

How does OCV make money?

One revenue line is on record: fund Management.

Who are OCV's main competitors?

Direct peers on record are Khosla Ventures, Polaris Partners, Artis Ventures, MizMaa Ventures, D1 Capital Partners and ArrowMark Partners. Broad incumbents are Andreessen Horowitz (a16z), General Catalyst and Bessemer Venture Partners. Section 32 is listed as an emerging player.

Does OCV have an API?

No public API is recorded for OCV.

What industry is OCV in?

OCV's product category is Venture Capital. Its primary akta.pro industry code is FSANAAAC, Late-Stage Venture Capital (Series C+), with a secondary code of FSANACAA, Technology & Software Growth Equity. Its NAICS code is 523940 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals